What is the share price of Rossari Biotech Ltd (ROSSARI) today?
The share price of ROSSARI as on 9th June 2026 is ₹515.60. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Rossari Biotech Ltd (ROSSARI) share?
The past returns of Rossari Biotech Ltd (ROSSARI) share are- Past 1 week: -0.84%
- Past 1 month: -2.90%
- Past 3 months: 12.59%
- Past 6 months: -11.36%
- Past 1 year: -24.88%
- Past 3 years: -38.96%
- Past 5 years: -58.85%
What are the peers or stocks similar to Rossari Biotech Ltd (ROSSARI)?
The peers or stocks similar to Rossari Biotech Ltd (ROSSARI) include:What is the dividend yield % of Rossari Biotech Ltd (ROSSARI) share?
The current dividend yield of Rossari Biotech Ltd (ROSSARI) is 0.10.What is the market cap of Rossari Biotech Ltd (ROSSARI) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Rossari Biotech Ltd (ROSSARI) is ₹2855.99 Cr as of 9th June 2026.What is the 52 week high and low of Rossari Biotech Ltd (ROSSARI) share?
The 52-week high of Rossari Biotech Ltd (ROSSARI) is ₹766 and the 52-week low is ₹375.What is the PE and PB ratio of Rossari Biotech Ltd (ROSSARI) stock?
The P/E (price-to-earnings) ratio of Rossari Biotech Ltd (ROSSARI) is 19.14. The P/B (price-to-book) ratio is 2.41.Which sector does Rossari Biotech Ltd (ROSSARI) belong to?
Rossari Biotech Ltd (ROSSARI) belongs to the Materials sector & Specialty Chemicals sub-sector.How to buy Rossari Biotech Ltd (ROSSARI) shares?
You can directly buy Rossari Biotech Ltd (ROSSARI) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Rossari Biotech Ltd
ROSSARI Share Price
NSE₹515.600.73% (+3.75)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ROSSARI Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
ROSSARI Performance & Key Metrics
ROSSARI Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 19.14 | 2.41 | 0.10% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 23.30 | 3.28 | 2.11% |
75%
Analysts have suggested that investors can buy this stock
from 4 analysts
Price Upside
Earnings Growth
Rev. Growth
ROSSARI Company Profile
Rossari Biotech is engaged in business of textile and specialty chemical manufacturing.
FLUOROCHEM
PE Ratio
68.49
68.49
1Y Return
1.68%
1.68%
Buy Reco %
72.73
72.73
NAVINFLUOR
PE Ratio
52.78
52.78
1Y Return
54.84%
54.84%
Buy Reco %
80.77
80.77
AARTIIND
PE Ratio
38.12
38.12
1Y Return
8.94%
8.94%
Buy Reco %
83.33
83.33
AETHER
PE Ratio
68.64
68.64
1Y Return
40.29%
40.29%
Buy Reco %
100.00
100.00
FINEORG
PE Ratio
34.83
34.83
1Y Return
1.05%
1.05%
Buy Reco %
80.00
80.00
ROSSARI Sentiment Analysis
ROSSARI Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
ROSSARI Stock Summary · May 2026
In Q4 FY26, the company achieved record revenue and EBITDA, driven by robust operational execution and a strategic focus on innovation, particularly in sustainable chemistries. Despite external challenges like raw material volatility, it reported a 15% revenue growth for the year, bolstered by a strong pipeline of projects and a commitment to expanding its pharmaceutical portfolio. The establishment of a new R&D facility and enhancements in manufacturing capacity are set to improve supply reliability and customer service. While navigating a competitive landscape, the company is strategically pursuing international expansion and optimizing its capital expenditures to enhance profitability, aiming for a debt-free status within 18 months. Overall, management remains optimistic about future demand and growth prospects, particularly in high-margin sectors.
ROSSARI Stock Growth Drivers
ROSSARI Stock Growth Drivers
8Strong Financial Performance
The company reported a strong finish to FY26, achieving its highest-ever quarterly revenue and EBITDA
Commitment to R&D and Innovation
The company has emphasized its commitment to research and development, transitioning towards broader platform technologies
ROSSARI Stock Challenges
ROSSARI Stock Challenges
4Declining Margins
The company has experienced a decline in EBITDA margins, with the margin for Q4 FY26
Postponement of Capital Expenditures
The company has postponed its capital expenditures (CAPEX), particularly regarding ethoxylation capacities, due to delays
ROSSARI Forecast
ROSSARI Forecasts
Price
Revenue
Earnings
ROSSARI Share Price Forecast
ROSSARI Share Price Forecast
2026
Current
₹515.60
Baseline
Forecast for Jun 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹515.60
Baseline
Forecast for Jun 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
ROSSARI Company Revenue Forecast
ROSSARI Company Revenue Forecast
2026
Current
₹2.42
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2026
Current
₹2.42
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
ROSSARI Stock EPS (Earnings Per Share) Forecast
ROSSARI Stock EPS (Earnings Per Share) Forecast
2026
Current
₹26.95
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹26.95
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
ROSSARI
ROSSARI
Income
Balance Sheet
Cash Flow
Quarterly Normal View
ROSSARI Income Statement
ROSSARI Income Statement
Quarterly Normal View
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 467.29 | 473.29 | 490.81 | 499.36 | 513.61 | 581.50 | 545.44 | 588.18 | 582.59 | 704.44 | ||||||||||
Operating & Other expenses | 400.10 | 409.12 | 424.76 | 432.41 | 447.97 | 510.07 | 475.86 | 514.18 | 512.81 | 607.61 | ||||||||||
EBITDA | 67.19 | 64.17 | 66.05 | 66.95 | 65.64 | 71.43 | 69.58 | 74.00 | 69.78 | 96.83 | ||||||||||
| Depreciation/Amortization | 15.09 | 16.07 | 15.37 | 15.16 | 18.32 | 18.22 | 17.75 | 18.23 | 19.61 | 23.53 | ||||||||||
| PBIT | 52.10 | 48.10 | 50.68 | 51.79 | 47.32 | 53.21 | 51.83 | 55.77 | 50.17 | 73.30 | ||||||||||
| Interest & Other Items | 4.32 | 2.52 | 3.69 | 3.68 | 4.94 | 5.50 | 5.73 | 6.09 | 7.67 | 9.06 | ||||||||||
| PBT | 47.78 | 45.58 | 46.99 | 48.11 | 42.38 | 47.71 | 46.10 | 49.68 | 42.50 | 64.24 | ||||||||||
| Taxes & Other Items | 13.39 | 11.44 | 12.09 | 12.78 | 10.67 | 13.26 | 12.51 | 12.79 | 9.73 | 18.28 | ||||||||||
| Net Income | 34.39 | 34.14 | 34.90 | 35.33 | 31.71 | 34.45 | 33.59 | 36.89 | 32.77 | 45.96 | ||||||||||
| EPS | 6.23 | 6.18 | 6.32 | 6.39 | 5.73 | 6.22 | 6.07 | 6.66 | 5.92 | 8.30 |
ROSSARI Company Updates
FY 2026FY 2026
Investor Presentation
Apr 28PDF
Jan 18PDF
Oct 16PDF
Jul 20PDF
ROSSARI Stock Peers
ROSSARI Past Performance & Peer Comparison
ROSSARI Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsSpecialty Chemicals
Compare valuation on Screener
MaterialsSpecialty Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Rossari Biotech Ltd | 19.14 | 2.41 | 0.10% |
| Gujarat Fluorochemicals Ltd | 68.49 | 5.39 | — |
| Navin Fluorine International Ltd | 52.78 | 13.34 | 0.21% |
| Aarti Industries Ltd | 38.12 | 2.85 | 0.23% |
ROSSARI Stock Price Comparison
Compare ROSSARI with any stock or ETFCompare ROSSARI with any stock or ETF
ROSSARI
ROSSARI Holdings
ROSSARI Shareholdings
ROSSARI Promoter Holdings Trend
ROSSARI Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
ROSSARI Institutional Holdings Trend
ROSSARI Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ROSSARI Shareholding Pattern
ROSSARI Shareholding Pattern
ROSSARI Shareholding History
ROSSARI Shareholding History
Foreign Institutions
Mutual Funds Invested in ROSSARI
Mutual Funds Invested in ROSSARI
No mutual funds holding trends are available
Top 5 Mutual Funds holding Rossari Biotech Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 3.1110% | Percentage of the fund’s portfolio invested in the stock 0.40% | Change in the portfolio weight of the stock over the last 3 months 0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 52/62 (+1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.7978% | Percentage of the fund’s portfolio invested in the stock 0.38% | Change in the portfolio weight of the stock over the last 3 months -0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 89/97 (-1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.3809% | Percentage of the fund’s portfolio invested in the stock 0.63% | Change in the portfolio weight of the stock over the last 3 months -0.12% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 51/61 (-1) |
Compare 3-month MF holding change on Screener
smallcases containing ROSSARI stock
smallcases containing ROSSARI stock
Looks like this stock is not in any smallcase yet.
ROSSARI Events
ROSSARI Events
ROSSARI Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ROSSARI has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.10%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹0.97 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ROSSARI Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ROSSARI has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.10%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹0.97 every year
ROSSARI Upcoming Dividends
ROSSARI Upcoming Dividends
No upcoming dividends are available
ROSSARI Past Dividends
ROSSARI Past Dividends
Cash Dividend
Ex DateEx DateJun 20, 2025
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Jun 20, 2025
Cash Dividend
Ex DateEx DateAug 16, 2024
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Aug 16, 2024
Cash Dividend
Ex DateEx DateMay 24, 2023
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
May 24, 2023
Cash Dividend
Ex DateEx DateJul 7, 2022
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Jul 7, 2022
Cash Dividend
Ex DateEx DateSep 8, 2021
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Sep 8, 2021
ROSSARI Stock News & Opinions
ROSSARI Stock News & Opinions
Articles & Videos
Corporate
Corporate
Board of Rossari Biotech recommends final dividendRossari Biotech announced that the Board of Directors of the Company at its meeting held on 27 April 2026, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 25%) , subject to the approval of the shareholders.
1 month agoCapital Market - Live
Earnings
Earnings
Rossari Biotech consolidated net profit rises 33.48% in the March 2026 quarterNet profit of Rossari Biotech rose 33.48% to Rs 45.97 crore in the quarter ended March 2026 as against Rs 34.44 crore during the previous quarter ended March 2025. Sales rose 18.17% to Rs 684.86 crore in the quarter ended March 2026 as against Rs 579.56 crore during the previous quarter ended March 2025. For the full year,net profit rose 9.41% to Rs 149.21 crore in the year ended March 2026 as against Rs 136.38 crore during the previous year ended March 2025. Sales rose 15.19% to Rs 2396.37 crore in the year ended March 2026 as against Rs 2080.29 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales684.86579.56 18 2396.372080.29 15 OPM %11.2811.99 -11.9312.74 - PBDT87.7765.93 33 281.64252.26 12 PBT64.2447.71 35 202.52185.19 9 NP45.9734.44 33 149.21136.38 9 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Corporate
Rossari Biotech allots 8,250 equity shares under ESOPRossari Biotech has allotted 8,250 equity shares under ESOP on 27 April 2026. With this allotment, the paid up equity share capital has increased to Rs. 11,07,83,232 consisting of 55391616 equity shares of Rs. 2/- each.
1 month agoCapital Market - Live
Corporate
Corporate
Rossari Biotech sets up new R&D facility at Navi MumbaiThe board of Rossari Biotech at its meeting held on 27 April 2026 has approved the relocation and shifting of the Company's existing Research and Development Facility located at IIT Bombay to Ellora Olearise, A-786, 06th Floor, Khairane MIDC, Koparkhairane, Navi Mumbai - 400 710. The company has set up a new Research and Development Facility at Navi Mumbai located at Ellora Olearise, A-786, 06th Floor, Khairane MIDC, Koparkhairane, Navi Mumbai - 400 710.
1 month agoCapital Market - Live
Corporate
Corporate
Rossari Biotech to announce Quarterly ResultRossari Biotech will hold a meeting of the Board of Directors of the Company on 27 April 2026.
1 month agoCapital Market - Live
Earnings
Earnings
Rossari Biotech consolidated net profit rises 3.38% in the December 2025 quarterNet profit of Rossari Biotech rose 3.38% to Rs 32.77 crore in the quarter ended December 2025 as against Rs 31.70 crore during the previous quarter ended December 2024. Sales rose 13.45% to Rs 581.68 crore in the quarter ended December 2025 as against Rs 512.73 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales581.68512.73 13 OPM %11.8412.63 - PBDT62.1260.70 2 PBT42.5042.38 0 NP32.7731.70 3 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Corporate
Rossari Biotech to announce Quarterly ResultRossari Biotech will hold a meeting of the Board of Directors of the Company on 17 January 2026.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Corporate
Rossari Biotech board approves incorporation of subsidiary in SingaporeThe board of Rossari Biotech at its meeting held on 18 December 2025 has approved the incorporation of a wholly owned subsidiary in Republic of Singapore with an initial investment of up to USD 10 million in tranches. Powered by Capital Market - Live
5 months agoCapital Market - Live
Spotlight
Spotlight
Rossari Biotech gains after Q2 PAT rises 4% YoY to Rs 37 crRevenue from operations jumped 17.61% YoY to Rs 586.11 crore in the second quarter of FY26, compared to Rs 498.35 crore in the corresponding quarter of the previous year. Profit before tax (PBT) stood at Rs 49.67 crore for the quarter ended 30 September 2025, up 3.24% from Rs 48.11 crore in Q2 FY25. Total expenses rose 19.33% YoY to Rs 538.51 crore during the quarter. The cost of materials consumed increased 25.54% to Rs 407.21 crore, employee benefit expenses rose 16.09% to Rs 37.80 crore and finance costs surged 65.48% to Rs 6.09 crore during the period under review. On a half-yearly basis, the company's consolidated net profit grew 0.34% YoY to Rs 70.47 crore, while revenue rose 14.35% YoY to Rs 1,129.82 crore in H1 FY26 over H1 FY25. Meanwhile, the company's board has approved an additional investment of up to $8 million, in one or more tranches, in Rossari International Company (RILC). The purpose of the investment is to support RILC's manufacturing and trading activities, including the distribution and sales of chemicals and consumer products. The proposed investment is aimed at supporting the business operations and other requirements of RILC. Rossari Biotech is a specialty-chemicals manufacturer providing intelligent and sustainable solutions for customers across industries. Headquartered in Mumbai, India, the company operates strategically located manufacturing facilities at Silvassa and Dahej. The company offers tailor-made solutions for Home, Personal Care and Performance Chemicals (HPPC); Textile Specialty Chemicals; and Animal Health and Nutrition (AHN). With differentiated product offerings, Rossari caters to an array of applications across FMCG, home care, industrial cleaning, personal care, textile specialty chemicals, performance chemicals, animal health and nutrition, and pet care businesses. The company has an extensive and dedicated network of distributors spread all over India. Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Earnings
Rossari Biotech consolidated net profit rises 4.39% in the September 2025 quarterNet profit of Rossari Biotech rose 4.39% to Rs 36.88 crore in the quarter ended September 2025 as against Rs 35.33 crore during the previous quarter ended September 2024. Sales rose 17.61% to Rs 586.11 crore in the quarter ended September 2025 as against Rs 498.35 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales586.11498.35 18 OPM %12.2713.23 - PBDT67.9163.27 7 PBT49.6748.11 3 NP36.8835.33 4 Powered by Capital Market - Live
7 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 28.13%, vs industry avg of 11.23%
Over the last 5 years, market share increased from 1.02% to 1.86%
Over the last 5 years, net income has grown at a yearly rate of 15.89%, vs industry avg of 6.44%